About RadNet, Inc.
https://www.radnet.comRadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
CEO
Howard G. Berger
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2006-11-28 | Reverse | 1:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 177
Ratings Snapshot
Rating : D+
Most Recent Analyst Grades
Raymond James
Strong Buy
B. Riley Securities
Buy
Truist Securities
Buy
Jefferies
Buy
Barclays
Overweight
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:9.61M
Value:$700.26M
BLACKROCK, INC.
Shares:9.45M
Value:$689.17M
VANGUARD GROUP INC
Shares:7.48M
Value:$545.57M
Summary
Showing Top 3 of 381
About RadNet, Inc.
https://www.radnet.comRadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $522.87M ▲ | $45.1M ▲ | $5.42M ▼ | 1.04% ▼ | $0.07 ▼ | $77.43M ▲ |
| Q2-2025 | $498.23M ▲ | $38.27M ▼ | $14.45M ▲ | 2.9% ▲ | $0.19 ▲ | $77.04M ▲ |
| Q1-2025 | $471.4M ▼ | $42.02M ▲ | $-37.93M ▼ | -8.05% ▼ | $-0.51 ▼ | $19.59M ▼ |
| Q4-2024 | $477.1M ▲ | $41.14M ▲ | $5.34M ▲ | 1.12% ▲ | $0.07 ▲ | $65.74M ▼ |
| Q3-2024 | $461.14M | $35.43M | $3.21M | 0.7% | $0.04 | $71M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $804.72M ▼ | $3.67B ▲ | $2.35B ▲ | $1.06B ▲ |
| Q2-2025 | $833.15M ▲ | $3.51B ▲ | $2.34B ▲ | $932.31M ▲ |
| Q1-2025 | $717.32M ▼ | $3.34B ▲ | $2.2B ▲ | $898.14M ▼ |
| Q4-2024 | $740.02M ▼ | $3.29B ▲ | $2.15B ▼ | $902.31M ▲ |
| Q3-2024 | $748.92M | $3.28B | $2.16B | $895.31M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $13.89M ▼ | $52.83M ▼ | $-75.72M ▲ | $-5.32M ▼ | $-28.44M ▼ | $-7.62M ▼ |
| Q2-2025 | $14.45M ▲ | $120.35M ▲ | $-97.45M ▼ | $92.43M ▲ | $115.83M ▲ | $67.41M ▲ |
| Q1-2025 | $-29.74M ▼ | $41.48M ▼ | $-56.75M ▼ | $-7.51M ▼ | $-22.7M ▼ | $-7.35M ▼ |
| Q4-2024 | $14.22M ▲ | $42.53M ▼ | $-48.81M ▼ | $-2.12M ▲ | $-8.9M ▼ | $-377K ▼ |
| Q3-2024 | $12.26M | $57.4M | $-45.98M | $-4.33M | $7.24M | $16.34M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Capitation Arrangements | $70.00M ▲ | $30.00M ▼ | $30.00M ▲ | $30.00M ▲ |
 Commercial Insurance1 | $520.00M ▲ | $260.00M ▼ | $280.00M ▲ | $290.00M ▲ |
 Health Care Management Service | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 Health Care Other | $30.00M ▲ | $10.00M ▼ | $10.00M ▲ | $20.00M ▲ |
 Medicaid1 | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
 Medicare1 | $210.00M ▲ | $110.00M ▼ | $120.00M ▲ | $120.00M ▲ |
 Workers CompensationPersonal Injury1 | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
CEO
Howard G. Berger
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2006-11-28 | Reverse | 1:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 177
Ratings Snapshot
Rating : D+
Most Recent Analyst Grades
Raymond James
Strong Buy
B. Riley Securities
Buy
Truist Securities
Buy
Jefferies
Buy
Barclays
Overweight
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:9.61M
Value:$700.26M
BLACKROCK, INC.
Shares:9.45M
Value:$689.17M
VANGUARD GROUP INC
Shares:7.48M
Value:$545.57M
Summary
Showing Top 3 of 381